Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study
Tài liệu tham khảo
2005, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet, 365, 1687, 10.1016/S0140-6736(05)66544-0
van de Water, 2012, Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer, JAMA, 307, 590, 10.1001/jama.2012.84
Berry, 2010, Competing risk of death: an important consideration in studies of older adults, J Am Geriatr Soc, 58, 783, 10.1111/j.1532-5415.2010.02767.x
Ravdin, 2001, Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer, J Clin Oncol, 19, 980, 10.1200/JCO.2001.19.4.980
Olivotto, 2005, Population-based validation of the prognostic model ADJUVANT! for early breast cancer, J Clin Oncol, 23, 2716, 10.1200/JCO.2005.06.178
Mook, 2009, Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study, Lancet Oncol, 10, 1070, 10.1016/S1470-2045(09)70254-2
Hajage, 2011, External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement, PLoS One, 6, e27446, 10.1371/journal.pone.0027446
Campbell, 2009, An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom, Br J Cancer, 101, 1074, 10.1038/sj.bjc.6605283
Yao-Lung, 2012, Accuracy validation of adjuvant! online in Taiwanese breast cancer patients—a 10-year analysis, BMC Med Inform Decis Mak, 12, 108, 10.1186/1472-6947-12-108
Bhoo-Pathy, 2012, Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients, Eur J Cancer, 48, 982, 10.1016/j.ejca.2012.01.034
Engelhardt, 2013, Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models, J Clin Oncol, 32, 238, 10.1200/JCO.2013.50.3417
NABON. Richtlijn Mammacarcinoom versie 2.0. 13-2-2012. [in Dutch] (accessed April 10, 2014).
Wildiers, 2007, Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology, Lancet Oncol, 8, 1101, 10.1016/S1470-2045(07)70378-9
Biganzoli, 2012, Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA), Lancet Oncol, 13, e148, 10.1016/S1470-2045(11)70383-7
Barnett, 2012, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study, Lancet, 380, 37, 10.1016/S0140-6736(12)60240-2
Patnaik, 2011, The influence of comorbidities on overall survival among older women diagnosed with breast cancer, J Natl Cancer Inst, 103, 1101, 10.1093/jnci/djr188
Kendal, 2008, Dying with cancer: the influence of age, comorbidity, and cancer site, Cancer, 112, 1354, 10.1002/cncr.23315
de Glas, 2013, Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis, Breast Cancer Res Treat, 138, 561, 10.1007/s10549-013-2462-9
Kiderlen, 2013, Diabetes in relation to breast cancer relapse and all-cause mortality in elderly breast cancer patients: a FOCUS study analysis, Ann Oncol, 24, 3011, 10.1093/annonc/mdt367
1992, 10, 1
Jager, 2008, The analysis of survival data: the Kaplan-Meier method, Kidney Int, 74, 560, 10.1038/ki.2008.217
Mell, 2010, Predictors of competing mortality in early breast cancer, Cancer, 116, 5365, 10.1002/cncr.25370
Putter, 2007, Tutorial in biostatistics: competing risks and multi-state models, Stat Med, 26, 2389, 10.1002/sim.2712
Crowson, 2014, Assessing calibration of prognostic risk scores, Stat Methods Med Res
Heagerty, 2005, Survival model predictive accuracy and ROC curves, Biometrics, 61, 92, 10.1111/j.0006-341X.2005.030814.x
Akobeng, 2007, Understanding diagnostic tests 3: Receiver operating characteristic curves, Acta Paediatr, 96, 644, 10.1111/j.1651-2227.2006.00178.x
Bastiaannet, 2010, Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients, Breast Cancer Res Treat, 124, 801, 10.1007/s10549-010-0898-8
Zulman, 2011, Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials, J Gen Intern Med, 26, 783, 10.1007/s11606-010-1629-x
van de Water, 2014, External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancer, J Natl Cancer Inst, 106, dju051, 10.1093/jnci/dju051
Brain, 2012, ASTER 70s: Benefit of adjuvant chemotherapy for oestrogen receptor-positive HER2-negative breast carcinoma in women over 70 according to Genomic Grade. A French UNICANCER Geriatric Oncology Group (GERICO) and Breast Group (UCBG) multicentre phase III trial, Cancer Research, 72, OT3-3, 10.1158/0008-5472.SABCS12-OT3-3-10
Hu, 2013, Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival, Cancer, 119, 1900, 10.1002/cncr.27968
Goldoni, 2009, Misclassification of breast cancer as cause of death in a service screening area, Cancer Causes Control, 20, 533, 10.1007/s10552-008-9261-3
van de Water, 2012, Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis, Br J Surg, 99, 813, 10.1002/bjs.8743